Nantes Institute for Advanced Study

Nantes Institute for Advanced Study brings together researchers and intellectuals from every continent. They all have in common the fact that they consider the diversity of thought systems as an indispensable support to the institution of reason in a world destined to remain diverse and unpredictable. It is modeled on the inspiration of Princeton, where carefully selected researchers are able to benefit from temporary freedom from scheduling, teaching and administrative commitments to devote themselves to the advancement of fundamental knowledge, notably pushing back disciplinary, institutional and cultural boundaries. The IAS-Nantes was officially recognized as being of public utility. It entered the prestigious consortium SIAS (Some Institutes for Advanced Study) in 2015 alongside the 8 other leading IAS throughout the world: Princeton, Stanford, Harvard, North Carolina, Berlin, Uppsala, Wassenaar and Jerusalem.

Tecnea - Cemafroid

Tecnea - Cemafroid Group is the expert in the cold chain, refrigeration and air conditioning. With more than 70 years of experience, we offer to professionals our independent expertise to improve their performance and reduce their risks in the food and health sector. Our vision: refrigeration is the essential guarantee of quality and safety for the food, the health and the well-being of the populations in the respect of the environment to feed and cure 9 billion men in 2050. Our missions: To provide professionals and industrialists with our independent expertise for the choice, management and monitoring of the cold chain or air conditioning and refrigeration systems. Test, verify, evaluate, qualify and certify equipment and solutions, train men and ensure compliance. Contribute to improving the economic and environmental performance of companies and reduce risks. Our Values: Independence, impartiality, quality, responsiveness, reliability, trust, team spirit

DIACCURATE

Endocrine-resistant metastatic breast tumor, glioblastoma, refractory acute myeloid leukemia, … to beat incurable cancers, Diaccurate explores the new frontiers of oncology in search of daring novel therapeutic approaches able to save lives. Now in the clinic, the French biotech is currently developing 3 proprietary therapeutics with novel mechanisms of action across several development programs: - DIACC3010, an optimized S6 Kinase inhibitor, highly selective oral antitumoral agent that crosses the blood-brain barrier - DIACC2010, a sole-in-class KIF20A kinesin inhibitor, a novel oncology target, IV antitumoral agent with high selectivity towards cancer cells -DIACC2020, antibody drug conjugate using DIACC2010 as payload Co-founded by Truffle Capital, Diaccurate has forged alliances with leaders in academia and industry, including Pasteur Institute, Paoli-Calmettes Institute (Marseille, France) and now Merck KGaA (Darmstadt, Germany). It relies on a high-level management team led by Dominique Bridon, PhD and a world-class Scientific Advisory Board chaired by Prof. Tasuku Honjo, recipient of the 2018 Nobel Prize in Medicine.

THERADIS PHARMA

Theradis Pharma, an independent service company, with Pharmaceutical Establishment license, offers its international expertise for your clinical trials. With a vast experience in the field of clinical trials, we can offer you a professional, effective logistics management to optimise your costs and timelines. Our capabilities embrace not only the pharmaceutical and nutrition industry, but also medical device fields. Founded in 2006, Theradis Pharma has acquired solid experience and a reputation of excellence for all services related to clinical trial logistical support such as the management of Investigational Medicinal Products, the management of study materials and documents as well as the management of biological samples. Interface of High Technology and air transport, acting on an international level, Theradis Pharma is based in Cagnes-sur-Mer, between the Technological Park of Sophia Antipolis and the airport of Nice, the second French International Airport. The company is located in mixed-use premises of 1,500 m2, spread over two buildings, one dedicated to pharmaceutical activities and the second more specifically dedicated to biological samples.

Faséo

Faséo est bureau d'études créé par Benoît Géhin le 25 mars 2005 qui se base sur l'expérience de son dirigeant, lequel avait alors plus de quinze années d'expérience sur les chantiers et au sein de bureaux d'études. Faséo s'appuie aussi sur les énergies complémentaires d'une équipe d'ingénieurs, de techniciens, de projeteurs et de dessinateurs chacun experts dans leurs spécialités respectives. Depuis bientôt 12 ans, Faséo a su gagner la confiance de ses clients concernant l'ingénierie de leurs projets. Que ce soient de la maitrise d'œuvre, de l'assistance techniques, des études de faisabilité, des créations de cahier des charges, des dossiers de consultation, des évaluations de budget, des analyses techniques et financières des offres ou l'exécution des différents plans ou schémas, Faséo a su accompagner ceux qui lui ont fait confiance. Mais Faséo est surtout une entreprise dynamique qui cherche sans cesse à adapter son savoir-faire à l'évolution rapide de l'univers du bâtiment. Initialement bureau d'études en électricité, nous avons rapidement su évoluer avec les progrès actuels en travaillant par exemple sur des projets tous fluides, en apprenant à maîtriser la gestion technique (domotique, GTB et GTC) et les énergies renouvelables. Soucieux de la trace que nous laisserons, nous cherchons toujours à favoriser des solutions respectueuses de l'environnement.